Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,252 public trials 1,192 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer

NCT00280150

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • Batte Cancer Center at Northeast Medical Center Concord, North Carolina, United States
  • Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States
View Trial Details
Completed

LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib

NCT01685060

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
  • City of Hope National Medical Center Dept of Oncology 2 Duarte, California, United States
  • University of California at Los Angeles Reg-5 Los Angeles, California, United States
  • University of California at San Diego, Moores Cancer Ctr SC San Diego, California, United States
View all 52 locations
View Trial Details
Completed

Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

NCT00550537

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
Locations
  • University of Florida Shands Cancer Center Gainesville, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
  • Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
View Trial Details
Completed

Safety and Pharmacokinetics of Escalating Doses of DNIB0600A in Participants With Non-Small Cell Lung Cancer (NSCLC) and Platinum Resistant Ovarian Cancer

NCT01363947

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +21 more
Locations
  • HonorHealth Research Institute - Pima Center Scottsdale, Arizona, United States
  • Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
  • Sarah Cannon Research Inst. Nashville, Tennessee, United States
  • Univ of Texas SW Medical Ctr Dallas, Texas, United States
View Trial Details
Completed

The Study Of An Oral Drug Called A Radiation Sensitizer In Patients With Newly Diagnosed Small Cell Lung Cancer (SCLC)

NCT00043862

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, Small Cell, +9 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Fountain Valley, California, United States
View all 31 locations
View Trial Details
Completed

Observational Study to Evalute the Efficacy and Safety of Avastin (Bevacizumab) in Addition to Platinum-Based Chemotherapy for First-Line Treatment of Participants With Non-Small Cell Lung Cancer

NCT03170284

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Ogyi, Orszagos Gyogyszereszeti Intezet Budapest, Hungary
  • Szent Imre Hospital; Dept. of Oncology Budapest, Hungary
  • Orszagos Koranyi TBC es Pulmonologiai Intezet Budapest, Hungary
  • Orszagos Onkologial Intezet; Onkologiai Osztaly X Budapest, Hungary
View all 33 locations
View Trial Details

Related conditions